A case of synchronous multiple primary lung adenocarcinomas harboring epidermal growth factor receptor mutation and anaplastic lymphoma kinase rearrangement successfully treated with combination of osimertinib and alectinib.

A case of synchronous multiple primary lung adenocarcinomas harboring epidermal growth factor receptor mutation and anaplastic lymphoma kinase rearrangement successfully treated with combination of osimertinib and alectinib.
复制标题

DOI:
10.1016/j.rmcr.2021.101418
复制
发表时间:
2021
影响因子:
1.1
通讯作者:
Jinn Y
Jinn Y
中科院分区:
其他
文献类型:
--
作者:
Inoue Y;Matsubara O;Ohira Y;Endo S;Jinn Y

文献摘要

参考文献

相似文献

同步性多原发性肺癌(SMPLC)应与肺内转移区分开来,以确定最佳治疗方法。表皮生长因子受体 (EGFR) 突变和间变性淋巴瘤激酶 (ALK) 重排通常是相互排斥的,两种突变共存的情况相对罕见。在此,我们报告了一例携带 EGFR 突变和 ALK 重排的 SMPLC 病例,使用奥希替尼和艾来替尼联合治疗成功治疗。 EGFR 和 ALK 酪氨酸激酶抑制剂的组合可能是具有 EGFR 突变和 ALK 重排的 SMPLC 的有效且可耐受的治疗选择。
Synchronous multiple primary lung cancers (SMPLC) should be distinguished from intrapulmonary metastasis to define the optimal treatment approach. Epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements are typically mutually exclusive and the co-existence of both mutations is relatively rare. Herein, we report a case of SMPLC harboring each EGFR mutation and ALK rearrangement successfully treated with combination of osimertinib and alectinib. A combination of EGFR- and ALK-tyrosine kinase inhibitors could be an effective and tolerable therapeutic option for SMPLC with EGFR mutations and ALK rearrangement.
DOI: 10.1093/annonc/mdt205
发表时间: 2013-09
期刊: Annals of oncology : official journal of the European Society for Medical Oncology
影响因子: --
作者:
Dearden S;Stevens J;Wu YL;Blowers D
通讯作者: Blowers D
DOI: 10.1097/pas.0b013e3181b8cf03
发表时间: 2009-12
期刊: The American journal of surgical pathology
影响因子: --
作者:
Girard N;Deshpande C;Lau C;Finley D;Rusch V;Pao W;Travis WD
通讯作者: Travis WD
DOI: 10.1158/0008-5472.can-11-1340
发表时间: 2011-09-15
期刊: Cancer research
影响因子: 11.2
作者:
Sasaki T;Koivunen J;Ogino A;Yanagita M;Nikiforow S;Zheng W;Lathan C;Marcoux JP;Du J;Okuda K;Capelletti M;Shimamura T;Ercan D;Stumpfova M;Xiao Y;Weremowicz S;Butaney M;Heon S;Wilner K;Christensen JG;Eck MJ;Wong KK;Lindeman N;Gray NS;Rodig SJ;Jänne PA
通讯作者: Jänne PA
DOI: 10.1056/nejmoa1704795
发表时间: 2017-08-31
影响因子: 158.5
作者:
Peters, Solange;Camidge, D. Ross;Mok, Tony
通讯作者: Mok, Tony
DOI: 10.1016/j.genrep.2018.03.018
发表时间: 2018-06-01
期刊: GENE REPORTS
影响因子: 1.3
作者:
Berradi, Hind;Kaanane, Houda;Nadifi, Sellama
通讯作者: Nadifi, Sellama